Algernon Pharmaceuticals Announces Ifenprodil (NP-120) an NDMA Receptor Antagonist as its Lead Drug That Reduced Fibrosis in a Recent Idiopathic Pulmonary Fibrosis Study by 56% July 29, 2019 - Canadian Stock Exchange News 0 » View More News for July 29, 2019
